Aghiad Chamdin
Experienced in Chronic Familial Neutropenia
Experienced in Chronic Familial Neutropenia
28050 Grand River Avenue, 
Farmington Hills, MI 

Overview

Aghiad Chamdin is a Pediatrics provider in Farmington Hills, Michigan. Dr. Chamdin has been practicing medicine for over 34 years and is rated as an Experienced provider by MediFind in the treatment of Chronic Familial Neutropenia. His top areas of expertise are Burkitt Lymphoma, Febrile Neutropenia, Sickle Cell Disease, Hemoglobinopathy, and Bone Marrow Aspiration. Dr. Chamdin is currently accepting new patients.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 21 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Damascus Faculty Of Human Medicine, 1991
Residency
Henry Ford St. John Hospital
Specialties
Pediatrics
Licenses
Pediatric Hematology-Oncology in MI
Board Certifications
American Board Of Pediatrics
American Board Of Pediatrics
Fellowships
Wayne State University School of Medicine GME
Hospital Affiliations
Corewell Health Farmington Hills Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Corewell Health Hospitalist - Farmington Hills
28050 Grand River Avenue, Farmington Hills, MI 48336

Additional Areas of Focus

Dr. Chamdin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


21 Clinical Trials

A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
View 15 Less Clinical Trials
Similar Doctors
Experienced in Chronic Familial Neutropenia
Pediatrics | Hematology | Oncology
Experienced in Chronic Familial Neutropenia
Pediatrics | Hematology | Oncology

Regents Of The University Of Michigan

1500 E Medical Ctr Dr, 
Ann Arbor, MI 
 (34.8 miles away)
Languages Spoken:
English
Accepting New Patients

Mary Mcgrath is a Pediatrics specialist and a Hematologist in Ann Arbor, Michigan. Dr. Mcgrath is rated as an Advanced provider by MediFind in the treatment of Chronic Familial Neutropenia. Her top areas of expertise are Factor 11 Deficiency, Hemophilia A, Hemophilic Arthropathy, and Platelet Storage Pool Deficiency. Dr. Mcgrath is currently accepting new patients.

Experienced in Chronic Familial Neutropenia
Pediatrics | Pediatric Hematology Oncology | Hematology
Experienced in Chronic Familial Neutropenia
Pediatrics | Pediatric Hematology Oncology | Hematology

Regents Of The University Of Michigan

1500 E Medical Ctr Dr, 
Ann Arbor, MI 
 (34.8 miles away)
Languages Spoken:
English

Rama Rao is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in Ann Arbor, Michigan. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Chronic Familial Neutropenia. Her top areas of expertise are Osteosarcoma, Chondrosarcoma, Neuroblastoma, Hereditary Neuroblastoma, and Bone Marrow Aspiration.

Experienced in Chronic Familial Neutropenia
Pediatrics | Pediatric Hematology Oncology | Hematology
Experienced in Chronic Familial Neutropenia
Pediatrics | Pediatric Hematology Oncology | Hematology

Regents Of The University Of Michigan

1500 E Medical Ctr Dr, 
Ann Arbor, MI 
 (34.8 miles away)
Languages Spoken:
English
Accepting New Patients

David Svilar is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in Ann Arbor, Michigan. Dr. Svilar is rated as an Experienced provider by MediFind in the treatment of Chronic Familial Neutropenia. His top areas of expertise are Sickle Cell Disease, Hereditary Spherocytosis, Febrile Neutropenia, and Shwartzman Phenomenon. Dr. Svilar is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chamdin's expertise for a condition
ConditionClose
        View All 25 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile